Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
56 studies found for:    TNNT2
Show Display Options
Rank Status Study
1 Unknown  Nitrate and Exercise-induced Cardiac Troponin T in Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus
Interventions: Dietary Supplement: Dietary nitrate beverage;   Dietary Supplement: NaCl beverage
2 Not yet recruiting High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
Conditions: Acute Coronary Syndrome;   Chest Pain
Interventions: Procedure: Blood Sample;   Behavioral: HEART Score
3 Completed TnThs for Identification Myocardial Infarction
Condition: Acute Coronary Syndrome
Intervention:
4 Completed RISK Stratification Using a Combination of Cardiac Troponin T and Brain Natriuretic Peptide in Patients Receiving CRT-D
Condition: Heart Failure
Intervention: Device: Cardiac Resynchronization Therapy-Defibrillator
5 Completed Age Gender Left Ventricular Mass and Cardiac Troponin T
Condition: Heart Failure
Intervention:
6 Not yet recruiting Variations of High Sensitivity Troponin T in Neonates
Condition: Newborn; Newborn, Transient
Intervention: Biological: Troponin T blood level
7 Recruiting High Sensitivity cTnT Rules Out Cardiac Insufficiency Trial (TACIT)
Condition: Heart Failure
Intervention: Other: hsTnT level
8 Completed High Sensitivity Cardiac Troponin T in Patients With Atrial Fibrillation Admitted to an Emergency Department (ED)
Condition: Atrial Fibrillation
Intervention:
9 Completed Comparison Between High-sensitivity Cardiac Troponin T and Standard Tnl Assays in Early Cardiac Ischemia Detection
Condition: Acute Coronary Syndrome
Intervention:
10 Completed Early Risk Stratification in ED Chest Pain Patients
Condition: Acute Coronary Syndrome
Interventions: Biological: point-of-care test for H-FABP;   Radiation: Coronary CT Angiography;   Other: Thrombolysis in myocardial infarction score;   Biological: routine blood test for hs-cTnT;   Other: HEART score
11 Withdrawn N-Terminal Pro-B-Type Natriuretic Peptide and Troponin Levels as Markers of Hemodynamic Stability in Very Low Birth Weight Infants During the First Days of Life
Conditions: Hypotension;   Very Low Birth Weight Infants;   Ventricular Dysfunction;   Prematurity
Intervention:
12 Completed TnThs Predicting Evolving Non-STEMI
Condition: Acute Coronary Syndrome
Intervention:
13 Recruiting One-hour Troponin in a Low-prevalence Population of Acute Coronary Syndrome
Conditions: Non-ST Elevation Myocardial Infarction;   Acute Coronary Syndrome;   Angina, Unstable;   NSTEMI - Non-ST Segment Elevation MI
Intervention: Procedure: 1-hour hs-cTnT
14 Completed HsTnT in Stable Coronary Artery Disease
Condition: Coronary Artery Disease
Intervention: Other: Progress of CHD
15 Recruiting Accelerated Rule Out of Myocardial Infarction
Condition: Myocardial Infarction
Intervention: Procedure: Accelerated, combined biomarker rule-out strategy for MI
16 Completed Influence of Renal Function on the Circadian Variation of Cardiac Troponin
Condition: Chronic Kidney Diseases
Intervention:
17 Terminated Dexrazoxane as a Protective Agent in Anthracycline Treated Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Dexrazoxane hydrochloride
18 Not yet recruiting Does Ranolazine Decrease Biomarkers of Myocardial Damage in Diabetics
Conditions: Silent Myocardial Ischemia;   Type 2 Diabetes
Interventions: Drug: Ranolazine;   Drug: Placebo
19 Recruiting Biological Variation of Cardiac Biomarkers in Aortic Valve Stenosis
Condition: Aortic Valve Stenosis
Intervention: Other: No intervention
20 Withdrawn Markers of Anthracycline-Related Cardiac Muscle Injury
Conditions: Osteosarcoma;   Ewing's Sarcoma Family of Tumors;   Rhabdomyosarcoma;   Non-rhabdomyosarcoma Soft Tissue Sarcomas
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.